Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-07-29SXTP3Initial Statement of Beneficial OwnershipHIGH
This filing reports that Knight Therapeutics Inc. now directly owns 658,629 shares of common stock in 60 Degrees Pharmaceuticals, Inc. This represents a significant ownership stake, with Knight Therapeutics Inc. being identified as a ten percent owner. The transaction date was July 22, 2026. The filing was made on July...
Nano CapBiotechnology
2026-07-29BCAX3Power of Attorney for Christy J. OligerMEDIUM
This filing is an Exhibit 24, a Power of Attorney granted by Christy J. Oliger, a director of Bicara Therapeutics Inc. (BCAX), to specific individuals within the company and its legal counsel. The attorneys-in-fact are authorized to execute and file various U.S. Securities and Exchange Commission (SEC) forms on behalf ...
Small CapBiotechnology
2026-07-29IMTX3Power of Attorney for Immatics N.V.MEDIUM
This filing details a Power of Attorney granted by James Nelson Pepin, reporting owner, to Ephraim HofsΓ€Γ, Lorenzo Gerardi, and Mona Rinn. The attorneys-in-fact are authorized to maintain SEC EDGAR system credentials, execute and file Forms 3, 4, and 5 on behalf of Mr. Pepin in his capacity as a reporting person for Im...
Small CapBiotechnology
2026-07-2960 DEGREES PHARMACEUTICALS, INC.3Initial Statement of Beneficial OwnershipDuplicateHIGH
This filing reports that Knight Therapeutics Inc. now directly owns 658,629 shares of common stock in 60 Degrees Pharmaceuticals, Inc. This represents a significant ownership stake, with Knight Therapeutics Inc. being identified as a ten percent owner. The transaction date was July 22, 2026. The filing was made on July...
Nano CapBiotechnology
2026-07-29OKYO3OKYO Pharma CSO Rajkumar Patil Form 3 Filing - Initial Statement of Beneficial OwnershipMEDIUM
This is a Form 3 filing by Rajkumar V. Patil, Chief Scientific Officer of OKYO Pharma Ltd (ticker: OKYO), reporting his initial beneficial ownership in the company. The filing discloses Patil's direct holdings as of March 18, 2026, including both common stock and extensive option grants. Patil holds 16,667 shares of co...
Micro CapBiotechnology
2026-07-29Bicara Therapeutics Inc.3Power of Attorney for Christy J. OligerDuplicateMEDIUM
This filing is an Exhibit 24, a Power of Attorney granted by Christy J. Oliger, a director of Bicara Therapeutics Inc. (BCAX), to specific individuals within the company and its legal counsel. The attorneys-in-fact are authorized to execute and file various U.S. Securities and Exchange Commission (SEC) forms on behalf ...
Small CapBiotechnology
2026-07-29OKYO Pharma Ltd3OKYO Pharma CSO Rajkumar Patil Form 3 Filing - Initial Statement of Beneficial OwnershipDuplicateMEDIUM
This is a Form 3 filing by Rajkumar V. Patil, Chief Scientific Officer of OKYO Pharma Ltd (ticker: OKYO), reporting his initial beneficial ownership in the company. The filing discloses Patil's direct holdings as of March 18, 2026, including both common stock and extensive option grants. Patil holds 16,667 shares of co...
Micro CapBiotechnology
Sponsored
2026-07-29Immatics N.V.3Power of Attorney for Immatics N.V.DuplicateMEDIUM
This filing details a Power of Attorney granted by James Nelson Pepin, reporting owner, to Ephraim HofsΓ€Γ, Lorenzo Gerardi, and Mona Rinn. The attorneys-in-fact are authorized to maintain SEC EDGAR system credentials, execute and file Forms 3, 4, and 5 on behalf of Mr. Pepin in his capacity as a reporting person for Im...
Small CapBiotechnology